Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
This drug is different from hormones (including estrogens and progestins). It works by acting like...
Read moreQ. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
After intense research, the maker of anti-osteoporosis drug Evista is asking the FDA to approve its use against breast cancer. A related... Read more »
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Isn't it ironic? Just a couple of years after paying a fine for the illegal promotion of Evista as a breast cancer prevention drug,... Read more »
A new study indicates that raloxifene (sold under the brand name Evista) is safe and effective for treating osteoporosis in postmenopausal... Read more »
Source: Breastcancer.org
Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: reduce the risk of... Read more »
Source: Breastcancer.org
Chemical name: Evista Brand name: Raloxifene Class: SERM (selective estrogen receptor modulator) hormonal therapy. Tamoxifen and Fareston are other... Read more »